Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Endocrinology|December 27, 2012
The Ca2+-activated, large conductance K+-channel (BKCa) is a player in the LH/hCG signaling cascade in testicular Leydig cellsM E Matzkin, S Lauf, K Spinnler, et al.
Biochimica Et Biophysica Acta. General Subjects|June 12, 2022
Pleiotropic actions of melatonin in testicular peritubular myoid cells of immature Syrian hamstersEugenia Riviere, Soledad P Rossi, Yamil E Tavalieri, et al.
Reproductive Biology and Endocrinology : RB&E|December 4, 2010
Expression of the TGF-beta1 system in human testicular pathologiesCandela R Gonzalez, María E Matzkin, Mónica B Frungieri, et al.
Plos One|November 13, 2015
Psychostimulant-Induced Testicular Toxicity in Mice: Evidence of Cocaine and Caffeine Effects on the Local Dopaminergic SystemCandela R González, Betina González, María E Matzkin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 19, 2007
Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety resultsP D Delmas, C L Benhamou, Z Man, et al.
Molecular and Cellular Endocrinology|June 23, 2016
Reactive oxygen species (ROS) production triggered by prostaglandin D2 (PGD2) regulates lactate dehydrogenase (LDH) expression/activity in TM4 Sertoli cellsSoledad P Rossi, Stefanie Windschüttl, María E Matzkin, et al.
Experimental Gerontology|July 6, 2019
Aging in the Syrian hamster testis: Inflammatory-oxidative status and the impact of photoperiodM E Matzkin, P Valchi, E Riviere, et al.
Scientific Reports|November 6, 2019
Role of indoleamine 2,3-dioxygenase in testicular immune-privilegeGisela S Gualdoni, Patricia V Jacobo, Cristian M Sobarzo, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 4, 2012
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year dataM R McClung, J R Zanchetta, A Racewicz, et al.
Pageof 3